1,5AG (GlycoMark) story for clinicians
[7]
Consistency of SMBG data and 1,5AG in type 1 diabetes treated with pramlintide
Despite similar reductions in A1c, the change in 1,5AG was consistent with the improvement in PPG control in pramlintide-treated subjects, as measured by SMBG.
e-mail
Dr. Toshikazu Yamanouchi
Teikyo Univ.
